PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PRFX | PainReform | 2.63% | 27.5M |
PainReform Company Questions & Answers
Q
How do I buy PainReform (PRFX) stock?
A
You can purchase shares of PainReform (NASDAQ: PRFX) through any online brokerage.
Q
Who are PainReform's (PRFX) main competitors?
A
There are no as such competitors for PainReform.
Q
What is the target price for PainReform?
A
There is no analysis for PainReform
Q
How much is PainReform (PRFX) stock ?
A
The stock price for PainReform (NASDAQ: PRFX) is $2.73 last updated Fri May 07 2021 20:00:01 GMT+0000 (Coordinated Universal Time).
Q
When is the next PainReform (PRFX) dividend?
A
There are no upcoming dividends for PainReform.
Q
When is PainReform (NASDAQ:PRFX) reporting earnings?
A
PainReform’s Q2 earnings are confirmed after-market from now on August 8, 2021.
Q
When is the upcoming split for PRFX?
A
There is no upcoming split for PainReform.